Literature DB >> 28509218

Acute kidney injury due to acyclovir.

Cigdem Yildiz1, Yasemin Ozsurekci2, Safak Gucer3, Ali Bulent Cengiz2, Rezan Topaloglu4.   

Abstract

Acyclovir is an antiviral agent widely used in herpetic infections in children. Although acyclovir is generally well tolerated, severe nephrotoxicity has been reported in some cases. In this report, we present a 16-year-old girl who developed acute renal failure due to acyclovir treatment and who needed repetitive hemodialysis. Renal biopsy was performed in order to confirm the diagnosis. A diagnosis of drug-related acute tubulointerstitial nephritis with focal tubular necrosis was made.

Entities:  

Keywords:  Acute renal failure; Acyclovir; Repetitive hemodialysis

Year:  2012        PMID： 28509218      PMCID： PMC5411519          DOI： 10.1007/s13730-012-0035-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN： 2192-4449


  19 in total

Review 1.  Crystal-induced acute renal failure.

Authors:  M A Perazella
Journal:  Am J Med       Date:  1999-04       Impact factor: 4.965

2.  Low-dose acyclovir and acute renal failure.

Authors:  A Giustina; G Romanelli; A Cimino; G Brunori
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

3.  Case report: acyclovir neurotoxicity and nephrotoxicity--the role for hemodialysis.

Authors:  B F Krieble; D W Rudy; M R Glick; M D Clayman
Journal:  Am J Med Sci       Date:  1993-01       Impact factor: 2.378

4.  Acute interstitial nephritis due to methicillin.

Authors:  J E Galpin; J H Shinaberger; T M Stanley; M J Blumenkrantz; A S Bayer; G S Friedman; J Z Montgomerie; L B Guze; J W Coburn; R J Glassock
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

5.  Acyclovir-induced renal failure. Clinical course and histology.

Authors:  M H Sawyer; D E Webb; J E Balow; S E Straus
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

Review 6.  Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature.

Authors:  B N Becker; P Fall; C Hall; D Milam; J Leonard; A Glick; G Schulman
Journal:  Am J Kidney Dis       Date:  1993-10       Impact factor: 8.860

7.  Renal function after acyclovir intravenous injection.

Authors:  D Brigden; A E Rosling; N C Woods
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

8.  Acyclovir tolerance in humans.

Authors:  R E Keeney; L E Kirk; D Bridgen
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

9.  Acute renal failure in a child associated with acyclovir.

Authors:  P Vachvanichsanong; P Patamasucon; M Malagon; E S Moore
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

10.  Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis.

Authors:  E González; E Gutiérrez; C Galeano; C Chevia; P de Sequera; C Bernis; E G Parra; R Delgado; M Sanz; M Ortiz; M Goicoechea; C Quereda; T Olea; H Bouarich; Y Hernández; B Segovia; M Praga
Journal:  Kidney Int       Date:  2008-01-09       Impact factor: 10.612
View more
  19 in total

1.  In Vitro and In Vivo Activity, Tolerability, and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus 2 Genital Infection.

Authors:  James Hopkins; Tejabhiram Yadavalli; Rahul Suryawanshi; Farreh Qatanani; Ipsita Volety; Ram Koganti; Aqsa Iqbal; Deepak Shukla
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

Review 2.  Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea.

Authors:  Lulia Koujah; Rahul K Suryawanshi; Deepak Shukla
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

3.  PharmGKB summary: acyclovir/ganciclovir pathway.

Authors:  Maud Maillard; Li Gong; Rina Nishii; Jun J Yang; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2022-05-30       Impact factor: 2.000

4.  Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity.

Authors:  Abdullah M Al-Alawi; Juhaina Salim Al-Maqbali; Maria Al-Adawi; Anan Al-Jabri; Henrik Falhammar
Journal:  Saudi Pharm J       Date:  2022-03-26       Impact factor: 4.562

5.  Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform.

Authors:  Tejabhiram Yadavalli; Joshua Ames; David Wu; Benjamin Ramirez; Navya Bellamkonda; Deepak Shukla
Journal:  Eur J Pharm Biopharm       Date:  2022-03-21       Impact factor: 5.589

6.  BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines.

Authors:  Aqsa Iqbal; Rahul Suryawanshi; Tejabhiram Yadavalli; Ipsita Volety; Deepak Shukla
Journal:  Antiviral Res       Date:  2020-05-05       Impact factor: 5.970

Review 7.  Pathobiology and treatment of viral keratitis.

Authors:  Raghuram Koganti; Tejabhiram Yadavalli; Raza Ali Naqvi; Deepak Shukla; Afsar R Naqvi
Journal:  Exp Eye Res       Date:  2021-02-06       Impact factor: 3.467

8.  Oral acyclovir induced hypokalemia and acute tubular necrosis a case report.

Authors:  Jonathan S Chávez-Iñiguez; Ramón Medina-Gonzalez; Lilia Aguilar-Parra; Eduardo J Torres-Vázquez; Pablo Maggiani-Aguilera; Enrique Cervantes-Pérez; Guillermo García-García
Journal:  BMC Nephrol       Date:  2018-11-14       Impact factor: 2.388

9.  Outcomes with acyclovir treatment in herpes simplex encephalitis after surgery for solid CNS tumors: a case report and systematic review of the literature.

Authors:  Niloofar Yari; Ethan Alexander Benardete; Wencong Chen; Solomon Neba Ambe; Ekokobe Fonkem
Journal:  Neurooncol Pract       Date:  2019-04-22

10.  Incidence and predictors of intravenous acyclovir-induced nephrotoxicity.

Authors:  Rasmus K B Richelsen; Signe B Jensen; Henrik Nielsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-07       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.